We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03132675
Brief Title: Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment (Keynote-695)

First Submitted : April 24, 2017
First Submitted that Met QC Criteria : April 26, 2017
First Posted : April 28, 2017

Last Update Submitted that Met QC Criteria : March 24, 2023
Last Update Posted : March 27, 2023